Abstract
Alpiniae Oxyphyliae Fructus (AOF) (yizhi) is a frequently medicated Chinese herb for Alzheimer disease (AD) treatment. The present study investigated the components and potential mechanisms of AOF through network pharmacology analysis and molecular docking. The results showed that AOF contains at least 20 active ingredients and involves 184 target genes. A total of 301 AD-related genes were obtained from the DisGeNET, GeneCards, GEO, OMIM, and Alzheimer Disease: Genes databases. A total of 41 key targets were identified from the topology analysis of the AOF-AD target network. These key targets are involved in 105 signal pathways, such as the PI3K-Akt, HIF-1, and MAPK pathways, and can regulate gene transcription, cell death, cell proliferation, drug response, and protein phosphorylation. AOF’s active ingredients, Chrysin, Isocyperol, Izalpinin, Linolenic acid, CHEMBL489541, Oxyphyllenone A, Oxyphyllenone B, and Oxyphyllol C, show high affinity to targets, including PPARG, ESR1, and AKT1. These findings provide a new basis for AOF application and anti-AD study.
Similar content being viewed by others
Data availability
Data will be made available on reasonable request.
References
Ahmad F, Singh K, Das D, Gowaikar R, Shaw E, Ramachandran A, Rupanagudi KV, Kommaddi RP, Bennett DA, Ravindranath V (2017) Reactive oxygen species-mediated loss of synaptic Akt1 signaling leads to deficient activity-dependent protein translation early in Alzheimer’s disease. Antioxid Redox Signal 27:1269–1280. https://doi.org/10.1089/ars.2016.6860
Ahmed T, Zulfiqar A, Arguelles S, Rasekhian M, Nabavi SF, Silva AS, Nabavi SM (2020) Map kinase signaling as therapeutic target for neurodegeneration. Pharmacol Res 160:105090. https://doi.org/10.1016/j.phrs.2020.105090
Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David MO, Abdel-Wahhab MA (2017) Neuroprotective effect of nanodiamond in Alzheimer’s disease rat model: a pivotal role for modulating NF-κB and STAT3 signaling. Mol Neurobiol 54:1906–1918. https://doi.org/10.1007/s12035-016-9762-0
Alzheimer’s Association (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12:459–509. https://doi.org/10.1016/j.jalz.2016.03.001
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17–23. https://doi.org/10.1038/ng1934
Burley SK, Berman HM, Bhikadiya C, Bi C, Chen L, Di Costanzo L, Christie C, Dalenberg K, Duarte JM, Dutta S, Feng Z, Ghosh S, Goodsell DS, Green RK, Guranovic V, Guzenko D, Hudson BP, Kalro T, Liang Y, Lowe R, Namkoong H, Peisach E, Periskova I, Prlic A, Randle C, Rose A, Rose P, Sala R, Sekharan M, Shao C, Tan L, Tao YP, Valasatava Y, Voigt M, Westbrook J, Woo J, Yang H, Young J, Zhuravleva M, Zardecki C (2019) RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res 47:D464–D474. https://doi.org/10.1093/nar/gky1004
Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S (2017) Protein data bank (PDB): the single global macromolecular structure Archive. Methods Mol Biol 1607:627–641. https://doi.org/10.1007/978-1-4939-7000-1_26
Carrica L, Li L, Newville J, Kenton J, Gustus K, Brigman J, Cunningham LA (2019) Genetic inactivation of hypoxia inducible factor 1-alpha (HIF-1α) in adult hippocampal progenitors impairs neurogenesis and pattern discrimination learning. Neurobiol Learn Mem 157:79–85. https://doi.org/10.1016/j.nlm.2018.12.002
Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357–W364. https://doi.org/10.1093/nar/gkz382
Del Fabbro L, Rossito Goes A, Jesse CR, de Gomes MG, Cattelan Souza L, Lobo Ladd FV, Lobo Ladd AAB, Nunes Arantes RV, Reis Simionato A, Oliveira MS, Furian AF, Boeira SP (2019) Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson’s disease. Neurosci Lett 706:158–163. https://doi.org/10.1016/j.neulet.2019.05.036
Desale SE, Dubey T, Chinnathambi S (2020) α-Linolenic acid inhibits tau aggregation and modulates tau conformation. Int J Biol Macromol 166:687–693. https://doi.org/10.1016/j.ijbiomac.2020.10.226
Ferreira ST, Klein WL (2011) The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease. Neurobiol Learn Mem 96:529–543. https://doi.org/10.1016/j.nlm.2011.08.003
Ferrer I, Blanco R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 77:270–276. https://doi.org/10.1016/s0169-328x(00)00062-0
Gold PW (2021) The PPARg system in major depression: pathophysiologic and therapeutic implications. Int J Mol Sci 22:9248. https://doi.org/10.3390/ijms22179248
Haines JL (2018) Alzheimer disease: perspectives from epidemiology and genetics. J Law Med Ethics 46:694–698. https://doi.org/10.1177/1073110518804230
Hu Y, Chen W, Wu L, Jiang L, Liang N, Tan L, Liang M, Tang N (2019) TGF-β1 restores hippocampal synaptic plasticity and memory in Alzheimer model via the PI3K/Akt/Wnt/β-Catenin signaling pathway. J Mol Neurosci 67:142–149. https://doi.org/10.1007/s12031-018-1219-7
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57. https://doi.org/10.1038/nprot.2008.211
Jazvinšćak Jembrek M, Slade N, Hof PR, Šimić G (2018) The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Prog Neurobiol 168:104–127. https://doi.org/10.1016/j.pneurobio.2018.05.001
Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P (2008) STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 36:D684–D688. https://doi.org/10.1093/nar/gkm795
Li J, Du QZ, Li N, Du SZ, Sun Z (2021) Alpiniae oxyphyllae Fructus and Alzheimer’s disease: an update and current perspective on this traditional chinese medicine. Biomed Pharmacother 135:111167. https://doi.org/10.1016/j.biopha.2020.111167
Li S, Zhang B (2013) Traditional chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11:110–120. https://doi.org/10.1016/S1875-5364(13)60037-0
Li TF, Ma J, Han XW, Jia YX, Yuan HF, Shui SF, Guo D, Yan L (2019) Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway. Neurochem Int 129:104496. https://doi.org/10.1016/j.neuint.2019.104496
Litwiniuk A, Domańska A, Chmielowska M, Martyńska L, Bik W, Kalisz M (2020) The effects of alpha-linolenic acid on the secretory activity of astrocytes and β amyloid-associated neurodegeneration in differentiated SH-SY5Y cells: alpha-linolenic acid protects the SH-SY5Y cells against β amyloid toxicity. Oxid Med Cell Longev 2020:8908901. https://doi.org/10.1155/2020/8908901
Luo TT, Lu Y, Yan SK, Xiao X, Rong XL, Guo J (2020) Network pharmacology in research of chinese medicine formula: methodology, application and prospective. Chin J Integr Med 26:72–80. https://doi.org/10.1007/s11655-019-3064-0
Mooers BHM (2020) Shortcuts for faster image creation in PyMOL. Protein Sci 29:268–276. https://doi.org/10.1002/pro.3781
Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI (2017) DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res 45:D833–D839. https://doi.org/10.1093/nar/gkw943
PubChem, Identifier CID 5318691. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5318691#section=2D-Structure
PubChem, Identifier CID 44576208. URL: https://pubchem.ncbi.nlm.nih.gov/compound/44576208#section=2D-Structure
PubChem, Identifier CID 10262534. URL: https://pubchem.ncbi.nlm.nih.gov/compound/10262534#section=2D-Structure
PubChem, Identifier CID 44310512. URL: https://pubchem.ncbi.nlm.nih.gov/compound/44310512#section=2D-Structure
PubChem, Identifier CID 14076604. URL: https://pubchem.ncbi.nlm.nih.gov/compound/14076604#section=2D-Structure
PubChem, Identifier CID 5281607. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5281607#section=2D-Structure
PubChem, Identifier CID 637451. URL: https://pubchem.ncbi.nlm.nih.gov/compound/637451#section=2D-Structure
PubChem, Identifier CID 182645. URL: https://pubchem.ncbi.nlm.nih.gov/compound/182645#section=2D-Structure
PubChem, Identifier CID 11128252. URL: https://pubchem.ncbi.nlm.nih.gov/compound/11128252#section=2D-Structure
PubChem, Identifier CID 5280794. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5280794#section=2D-Structure
PubChem, Identifier CID 445639. URL: https://pubchem.ncbi.nlm.nih.gov/compound/445639#section=2D-Structure
PubChem, Identifier CID 5280934. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5280934#section=2D-Structure
PubChem, Identifier CID 5280450. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5280450#section=2D-Structure
PubChem, Identifier CID 1268142. URL: https://pubchem.ncbi.nlm.nih.gov/compound/1268142#section=2D-Structure
PubChem, Identifier CID 15560330. URL: https://pubchem.ncbi.nlm.nih.gov/compound/15560330#section=2D-Structure
PubChem, Identifier CID10857540. URL: https://pubchem.ncbi.nlm.nih.gov/compound/10857540#section=2D-Structure
PubChem, Identifier CID5281954. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5281954#section=2D-Structure
PubChem, Identifier CID222284. URL: https://pubchem.ncbi.nlm.nih.gov/compound/222284#section=2D-Structure
PubChem, Identifier CID10082923. URL: https://pubchem.ncbi.nlm.nih.gov/compound/10082923#section=2D-Structure
PubChem, Identifier CID5742590. URL: https://pubchem.ncbi.nlm.nih.gov/compound/5742590#section=2D-Structure
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. https://doi.org/10.1186/1758-2946-6-13
Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A, Lancet D (2010) GeneCards Version 3: the human gene integrator. Database (Oxford) 2010:baq020. https://doi.org/10.1093/database/baq020
Salau VF, Erukainure OL, Ayeni G, Ibeji CU, Islam MS (2021) Modulatory effect of ursolic acid on neurodegenerative activities in oxidative brain injury: an ex vivo study. J Food Biochem 45:e13597. https://doi.org/10.1111/jfbc.13597
Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer’s disease. Lancet 388(10043):505–517. https://doi.org/10.1016/S0140-6736(15)01124-1
Seo YJ, Jeong M, Lee KT, Jang DS, Choi JH (2016) Isocyperol, isolated from the rhizomes of Cyperus rotundus, inhibits LPS-induced inflammatory responses via suppression of the NF-κB and STAT3 pathways and ROS stress in LPS-stimulated RAW 264.7 cells. Int Immunopharmacol 38:61–69. https://doi.org/10.1016/j.intimp.2016.05.017
Shi G, Boerwinkle E, Morrison AC, Gu CC, Chakravarti A, Rao DC (2011) Mining gold dust under the genome wide significance level: a two-stage approach to analysis of GWAS. Genet Epidemiol 35:111–118. https://doi.org/10.1002/gepi.20556
Srinivasan R, Aruna A, Lee JS, Kim M, Shivakumar MS, Natarajan D (2020) Antioxidant and antiproliferative potential of bioactive molecules ursolic acid and thujone isolated from Memecylon edule and Elaeagnus indica and their inhibitory effect on topoisomerase II by molecular docking approach. Biomed Res Int 2020:8716927. https://doi.org/10.1155/2020/8716927
Shi SH, Zhang CN, Liu B, Liu Z, Bi KS (2013) Study on anti-senile dementia effect of different polar extracts of Alpinia Oxyphylla. Chin Pharm 24:2507–2510 (Chinese)
Sterling T, Irwin JJ (2015) ZINC 15–ligand discovery for everyone. J Chem Inf Model 55:2324–2337. https://doi.org/10.1021/acs.jcim.5b00559
Su G, Morris JH, Demchak B, Bader GD (2014) Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics 47:8.13.1–8.13.24. https://doi.org/10.1002/0471250953.bi0813s47
Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M (2015) STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44:D380-384. https://doi.org/10.1093/nar/gkv1277
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. https://doi.org/10.1002/jcc.21334
Wan Y, Zou B, Zeng HL, Zhang LN, Chen M, Fu GM (2016) Inhibitory effect of verbascoside on xanthine oxidase activity. Int J Biol Macromol 93:609–614. https://doi.org/10.1016/j.ijbiomac.2016.09.022
Wang T, Yao J, Chen S, Mao Z, Brinton RD (2020) Allopregnanolone reverses bioenergetic deficits in female triple transgenic Alzheimer’s mouse model. Neurotherapeutics 17:178–188. https://doi.org/10.1007/s13311-019-00793-6
Wang Y, Wang M, Fan K, Li T, Yan T, Wu B, Bi K, Jia Y (2018) Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer’s disease. J Ethnopharmacol 217:98–106. https://doi.org/10.1016/j.jep.2018.02.015
Xu HY, Zhang YQ, Liu ZM, Chen T, Lv CY, Tang SH, Zhang XB, Zhang W, Li ZY, Zhou RR, Yang HJ, Wang XJ, Huang LQ (2019) ETCM: an encyclopaedia of traditional chinese medicine. Nucleic Acids Res 47:D976–D982. https://doi.org/10.1093/nar/gky987
Xu SN, Zhuang L, Zhai Y, Yao WF, Xu J, Liu Q, Bao BH, Cao YD, Zhang L, Ding AW (2018) Study on the material basis and mechanism of Erzhi Pill for prevention and treatment of osteoporosis based on network pharmacology. Chin J Pharm 53:1913–1920 (Chinese)
Yang M (2019) TCM network pharmacology analysis system v1.0. Copyright Registration No. 2019SR1127090
Yuan ZZ, Pan YY, Leng T, Chu Y, Zhang HJ, Ma JR, Ma XJ (2022) Progress and prospects of research ideas and methods in the network pharmacology of traditional chinese medicine. J Pharm Pharm Sci 25:218–226. https://doi.org/10.18433/jpps32911
Funding
This study was supported by National Natural Science Foundation of China [grant number 81873246], Medical Innovation Research Program of Shanghai Municipality [grant number 21Y11920900], Collaborative Innovation Center project of Pharmaceutical Industry transformation in Hospital of Shanghai Municipality [grant number 2093], and Scientific and Technological Innovation Projects of Longhua Hospital [grant number CX202052].
Author information
Authors and Affiliations
Contributions
HMA and BH designed the study, coordinated technical support and funding; BH revised the manuscript; RRZ performed the study and drafted the manuscript; YJQ, LMZ, CG, MRD, LC and XP participated the study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to participate
Not applicable.
Consent to publish
All the authors listed have approved the manuscript that is enclosed.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhen, RR., Qu, YJ., Zhang, LM. et al. Exploring the potential anti-Alzheimer disease mechanisms of Alpiniae Oxyphyliae Fructus by network pharmacology study and molecular docking. Metab Brain Dis 38, 933–944 (2023). https://doi.org/10.1007/s11011-022-01137-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-01137-8